Sensus Healthcare, Inc. (SRTS) — SEC Filings
Sensus Healthcare, Inc. (SRTS) — 27 SEC filings. Latest: 8-K (May 7, 2026). Includes 16 8-K, 6 10-Q, 2 DEF 14A.
View Sensus Healthcare, Inc. on SEC EDGAR
Overview
Sensus Healthcare, Inc. (SRTS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Nov 13, 2025: Sensus Healthcare, Inc. announced on November 10, 2025, changes related to its board of directors and executive compensation. The filing details the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for key executives.
Sentiment Summary
Across 27 filings, the sentiment breakdown is: 2 bearish, 25 neutral. The dominant filing sentiment for Sensus Healthcare, Inc. is neutral.
Filing Type Overview
Sensus Healthcare, Inc. (SRTS) has filed 16 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 1 SC 13G/A with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (27)
Risk Profile
Risk Assessment: Of SRTS's 23 recent filings, 2 were flagged as high-risk, 3 as medium-risk, and 18 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $6.884M |
| Net Income | $(0.943)M |
| EPS | $(0.06) |
| Cash Position | $24.453M |
| Operating Margin | -37.3% |
| Total Assets | $58.295M |
| Total Debt | $7.101M |
Key Executives
- Class III directors
Industry Context
Sensus Healthcare operates in the medical device industry, specifically focusing on radiation oncology. The sector is characterized by long sales cycles, regulatory hurdles, and the need for continuous innovation. Companies in this space often rely on a few key customers or distributors, making customer concentration a common challenge.
Top Tags
corporate-governance (5) · 10-Q (4) · financial-condition (3) · results-of-operations (3) · financial-reporting (3) · financials (3) · 8-k (3) · Medical Devices (2) · Revenue Decline (2) · shareholder-vote (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Q3 2025 Revenue | $6.884M | Decreased by 22.1% from $8.839M in Q3 2024 |
| Q3 2025 Net Loss | $(0.943)M | Shifted from $1.215M net income in Q3 2024 |
| Q3 2025 Basic Net Loss Per Share | $(0.06) | Down from $0.07 basic net income per share in Q3 2024 |
| Nine-Month 2025 Revenue | $22.543M | Decreased by 21.5% from $28.741M in nine-month 2024 |
| Nine-Month 2025 Net Loss | $(4.552)M | Shifted from $5.101M net income in nine-month 2024 |
| Q3 2025 Total Operating Expenses | $5.282M | Increased by 41.0% from $3.745M in Q3 2024 |
| Cash and Cash Equivalents | $24.453M | As of September 30, 2025, up from $22.056M at December 31, 2024 |
| Revenue Concentration | 59% | From one U.S. customer for Q3 2025 |
| Accounts Receivable Concentration | 86% | From one U.S. customer as of September 30, 2025 |
| Net Cash Provided by Operating Activities | $2.735M | For the nine months ended September 30, 2025 |
| Q2 2025 Revenue | $7.23M | 48.6% decrease from Q2 2024 revenue of $14.06M |
| H1 2025 Revenue | $14.06M | 48.3% decrease from H1 2024 revenue of $27.23M |
| Q2 Revenue Decline | 48.6% | Year-over-year percentage decrease in total revenue for Q2 2025 |
| H1 Revenue Decline | 48.3% | Year-over-year percentage decrease in total revenue for the first six months of 2025 |
| Reporting Period End Date | 2025-03-31 | Indicates the end of the financial quarter being reported. |
Forward-Looking Statements
- {"claim":"Sensus Healthcare, Inc. will release its full financial results for the period covered by this 8-K within the next few weeks.","entity":"Sensus Healthcare, Inc.","targetDate":"2024-03-15","confidence":"high"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Sensus Healthcare, Inc. (SRTS)?
Sensus Healthcare, Inc. has 27 recent SEC filings from Jan 2024 to May 2026, including 16 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SRTS filings?
Across 27 filings, the sentiment breakdown is: 2 bearish, 25 neutral. The dominant sentiment is neutral.
Where can I find Sensus Healthcare, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Sensus Healthcare, Inc. (SRTS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Sensus Healthcare, Inc.?
Key financial highlights from Sensus Healthcare, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SRTS?
The investment thesis for SRTS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Sensus Healthcare, Inc.?
Key executives identified across Sensus Healthcare, Inc.'s filings include Class III directors.
What are the main risk factors for Sensus Healthcare, Inc. stock?
Of SRTS's 23 assessed filings, 2 were flagged high-risk, 3 medium-risk, and 18 low-risk.
What are recent predictions and forward guidance from Sensus Healthcare, Inc.?
Recent forward-looking statements from Sensus Healthcare, Inc. include guidance on {"claim":"Sensus Healthcare, Inc. will release its full financial results for the period covered by this 8-K within the .